Related content

Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer1

By An G.   Meka C.S.R.   Bright S.P.   Veltri R.W.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1105-1111

Elsevier

Access to resources Recommend Favorite

Increased expression of elongation factor-1α is significantly correlated with poor prognosis of human prostate cancer

By Liu Huaizheng   Ding Jian   Chen Fang   Fan Benyi   Gao Ning   Yang Zhongqing   Qi Lin  

Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 5, 2010-11 ,pp. : 277-283

Informa Healthcare

Access to resources Recommend Favorite

Pretreatment Serum Level of Neuron Specific Enolase (NSE) as a Prognostic Factor in Metastatic Prostate Cancer Patients Treated with Endocrine Therapy

By Kamiya N.   Akakura K.   Suzuki H.   Isshiki S.   Komiya A.   Ueda T.   Ito H.  

European Urology, Vol. 44, Iss. 3, 2003-09 ,pp. : 309-314

Elsevier

Access to resources Recommend Favorite

Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer

By Duque J.L.F.   Loughlin K.R.   Adam R.M.   Kantoff P.W.   Zurakowski D.   Freeman M.R.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 523-527

Elsevier

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor (EGFR) Expression is Associated With a Worse Prognosis in Gastric Cancer Patients Undergoing Curative Surgery

By Galizia Gennaro   Lieto Eva   Orditura Michele   Castellano Paolo   Mura Anna   Imperatore Vincenzo   Pinto Margherita   Zamboli Anna   Vita Ferdinando   Ferraraccio Francesca  

World Journal of Surgery, Vol. 31, Iss. 7, 2007-07 ,pp. : 1458-1468

Springer Publishing Company

Access to resources Recommend Favorite